North America continues to be the primary engine of growth for the cardiovascular diagnostics sector, specifically in the identification of asymptomatic or "silent" myocardial infarctions. As the region with the highest healthcare expenditure and a robust network of research institutions, North America is at the forefront of transitioning silent heart attack detection from reactive treatment to...